Intervention
Ganciclovir
ClinicalTrials.gov intervention label
Explore related research
Search across original and mapped recordsSearch results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 39 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
39 shownSafety, Tolerability and Pharmacokinetics Investigation of Stimotimagene CopolymerplasmidNCT05578820 · 2022-01-01
COMPLETEDHigh-dose Intravitreal Injection of Ganciclovir for the Treatment of CMVR in HIV-negative PatientsNCT03598452 · 2014-01-01
COMPLETEDIslet Transplantation for Type 1 DiabetesNCT00014911 · 2001-04-01
COMPLETEDA Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the EyesNCT00002377 · 1997-01-01
COMPLETEDStudies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT)NCT00000134 · 1992-12-01
COMPLETEDStudies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT)NCT00000136 · 1990-03-01
COMPLETEDA Randomized Study Comparing the Safety and Efficacy of Two Regimens of Oral Ganciclovir to Intravenous Ganciclovir Maintenance Therapy for Cytomegalovirus Retinitis in People With AIDS Who Have Received Prior Ganciclovir TherapyNCT00002247
COMPLETEDA Study of Two Forms of Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDSNCT00002330
COMPLETEDA Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus RetinitisNCT00002134
COMPLETEDGanciclovir: Compassionate Use in Patients With Serious or Life-Threatening Cytomegalovirus InfectionsNCT00002024
COMPLETEDA Phase I Pharmacokinetic Study in HIV-Positive Subjects of Oral Ganciclovir and Concomitant Antiretroviral Zidovudine and DidanosineNCT00002096
COMPLETEDA Multiple Dose Crossover Pharmacokinetics Study to Evaluate the Effects of Food on the Absorption of Oral GanciclovirNCT00002251
COMPLETEDA Study of Ganciclovir in the Treatment of Cytomegalovirus of the Large Intestine in Patients With AIDSNCT00002273
COMPLETEDA Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR )NCT00002156
COMPLETEDA Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDSNCT00001999
COMPLETEDA Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDSNCT00002257
COMPLETEDAn Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous AccessNCT00002135
COMPLETEDA Randomized, Double-Blind Study of the Efficacy and Safety of Oral Ganciclovir for the Prevention of CMV Disease in People Infected With the Human Immunodeficiency VirusNCT00002095
COMPLETEDOpen Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised PatientNCT00002025
COMPLETEDThe Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDSNCT00002299
COMPLETEDAn Open Label Evaluation of the Safety and Pharmacokinetics of Ganciclovir in ChildrenNCT00002015
COMPLETEDA Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDSNCT00002034
COMPLETEDComparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDSNCT00001061
COMPLETEDA Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With GanciclovirNCT00000970
COMPLETEDA Study of Ganciclovir in the Treatment of Cytomegalovirus of the EyesNCT00001062
COMPLETEDThe Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDSNCT00000989
COMPLETEDA Randomized Comparative Pharmacokinetic Study of Oral Ganciclovir After Treatment With Intravenous Ganciclovir for Cytomegalovirus Gastrointestinal Disease in AIDS PatientsNCT00000768
COMPLETEDThe Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIVNCT00001034
COMPLETEDA Study of AZT Plus Ganciclovir in Patients With AIDS and Cytomegalovirus (CMV) InfectionNCT00000995
COMPLETEDA Phase I Pharmacokinetic and Tolerance Study of 28-Day Regimens of Oral GanciclovirNCT00000668
COMPLETEDA Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus DiseaseNCT00000805
COMPLETEDPhase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV RetinitisNCT00002070
COMPLETEDA Phase I/II Pilot Treatment Study Of CSF Penetration And Response To Ganciclovir And Foscarnet In CMV Neurologic Disease.NCT00000856
WITHDRAWNA Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic TherapyNCT00000673
COMPLETEDStudies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir ComponentNCT00000665
COMPLETEDA Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDSNCT00000688
COMPLETEDCMV Retinitis Retreatment TrialNCT00000766
COMPLETEDComparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV RetinitisNCT00000894
COMPLETEDA Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV RetinitisNCT00000698
COMPLETEDCommon conditions
HIV Infections36Cytomegalovirus Retinitis27Cytomegalovirus Infections7Colitis2Acquired Immunodeficiency Syndrome1Anus Neoplasms1Breast Neoplasms1Diabetes Mellitus, Insulin-Dependent1Encephalopathy1Gastrointestinal Diseases1Infection Viral1Melanoma1Penile Neoplasms1Radiculitis1Sarcoma1Squamous Cell Carcinoma of Head and Neck1Uterine Cervical Neoplasms1Uveitis, Posterior1Vulvar Neoplasms1
Mapped diseases appearing in these trials
Shared study participation does not establish that this intervention treats a disease.
Leading sponsors
National Institute of Allergy and Infectious Diseases (NIAID)
17
Hoffmann-La Roche
12
Roche Global Development
3
Johns Hopkins Bloomberg School of Public Health
2
Aier School of Ophthalmology, Central South University
1
American National Red Cross
1
Gene Surgery LLC
1
Ionis Pharmaceuticals, Inc.
1
Schering-Plough
1
Trial status mix
COMPLETED38
WITHDRAWN1
Phase mix
NA18
PHASE19
PHASE36
PHASE25
PHASE41
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.